Doseloop Beta

Tolazamide

medication Under review

A sulfonylurea medication used to help control blood sugar levels in patients with type 2 diabetes.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Clinical research on tolazamide consists primarily of intervention studies in adults with type 2 diabetes, including randomized comparisons with other sulfonylureas and with exogenous insulin. These trials consistently show that tolazamide effectively lowers fasting blood glucose and glycosylated hemoglobin and can provide glycemic control comparable to that achieved with insulin in appropriately selected patients with residual beta-cell function. Other work indicates that improved glycemic control with tolazamide therapy is associated with normalization of whole-body glucose utilization toward nondiabetic levels in people with type 2 diabetes. The evidence base focuses on disease treatment rather than enhancement of health in otherwise healthy individuals. There are no controlled trials using tolazamide as a metabolic aid in healthy humans, and all efficacy data relate to patients with type 2 diabetes or related dysglycemia. Safety data from clinical use and prescribing information highlight hypoglycemia as the primary risk, along with infrequent dermatologic or gastrointestinal adverse effects. In contemporary guidelines, tolazamide is considered an older agent and is generally not used for wellness or performance purposes in healthy populations.

Reported Benefits

No side effects tracked yet

No side effects have been reported by studies or users for this habit yet.

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (3 studies)

Systematic Review

Tolazamide prescribing information (clinical safety and efficacy data)

FDA Product Labeling (Tolazamide Tablets) • 2019 • n=1784

U.S. Food and Drug Administration

RCT

A comparison of the effects of tolazamide and tolbutamide upon blood glucose, serum insulin, cholesterol and triglycerides in maturity-onset diabetes

Canadian Medical Association Journal • 1964 • n=20

Samaan N, Fraser R

RCT

CLINICAL STUDIES OF TOLAZAMIDE AND TOLBUTAMIDE: COMPARATIVE EFFECTIVENESS OF CONTROL OF DIABETES MELLITUS.

British Medical Journal • 1958 • n=12

Himsworth RL, Carrington SP

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 3
Researched benefits 2
Side effects noted 0